Sep 01 2022 ADSTEM Posted at 10:50h in by sharmila 0 Likes A phase I/II study to evaluate allogeneic mesenchymal stromal cells for the treatment of skin disease in adults with Recessive Dystrophic Epidermolysis Bullosa Read more
